SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-218731

Patient #053

Teo Yong Sheng · 55y · Male · Chinese · BMI 23.4 · ECOG 1
SVMC - Sunway Velocity · Cardiothoracic Surgery · Dr. Rajesh Kumar
IA2 (T1b, N0)Disease-free
ALK fusion
Clinical storyline

Teo Yong Sheng, a 55-year-old Chinese male (never, ECOG 1), presented in 2024-08 with exertional dyspnea. Workup confirmed Adenocarcinoma (Stage I, ALK fusion). The MDT recommended curative-intent surgery. Current status: Disease-free.

HPE Results
Well differentiated adenocarcinoma, acinar type stage 1A2, no LVI, no STATS
Clinical Stage
IA2 (T1b, N0)
Pathological Stage
IA2 (T1b, N0, Mx)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
1.8
Tumor (CT/PET)
1.7 cm
PET SUV
8.6
NGS Results
ALK fusion positive